Logos Global Management’s Tonix Pharmaceuticals TNXP Stock Holding History
Bought
Maintained
Sold
Other funds holding TNXP
JHC
Logos Global Management's TNXP Position: Q3 2026 in Review
Logos Global Management opened a new position in Tonix Pharmaceuticals (TNXP) in Q3 2026: 550,000 shares worth $5.36M. The stake represents 0.29% of the portfolio and ranks #57 among its holdings.
86 funds tracked by Wall St. Rank hold TNXP as of Q3 2026.
- Logos Global Management held 550,000 shares of Tonix Pharmaceuticals worth $5.36M as of Q3 2026.
- Tonix Pharmaceuticals was a new Logos Global Management position in Q3 2026.
- Tonix Pharmaceuticals made up 0.29% of Logos Global Management's portfolio in Q3 2026, its #57 holding.
- 86 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q3 2026.
Based on Logos Global Management's 13F filing for Q3 2026, filed 16 Nov 2026.